In addition, CXCL1 could be a diagnostic factor to observe whether high-grade prostate cancer has deteriorated [15], and the CXCL1/CXCR2 axis has been reported in the glial cells during neuropathic pain [21]. This evidence concerns the gene CXCR2 and prostate carcinoma.